Clinical Data AAN 2026: J&J, Kyverna, Capricor and Praxis showcase practice-changing data BioSpaceThis year's American Academy of Neurology meeting included a presentation that could one day set a new treatment standard for myasthenia gravis.Clinical DataNeuroscienceRead full story pharminent April 23, 2026 (Last updated: April 23, 2026) BioSpace This year’s American Academy of Neurology meeting included a presentation that could one day set a new treatment standard for myasthenia gravis. Clinical DataNeuroscienceRead full story Post navigation Previous: Minnesota’s 340B Hospitals Make One Billion More From 340B Than They Spend on Uncompensated CareNext: Roche insists amylin obesity drug still valuable for patients who ‘don’t want side effects’ Related Stories Clinical Data Novartis hit as Lp(a) drug fails cardio outcomes trial pharminent September 7, 2026 Clinical Data Major trial of Roche Alzheimer’s drug kicks off in Europe pharminent September 7, 2026 Clinical Data AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study pharminent September 4, 2026